🏥 Health 20h ago

View Channel →

0 0 Save Read Full Article Source ↗ 👁 0 💬 0

(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions.
Following a facility...

Sign in to join the discussion

📰

More REM sleep linked to lower risk of 83 diseases

Health & Medicine News -- ScienceDaily · 13h ago

📰

GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children

Health & Medicine News -- ScienceDaily · 13h ago

White House plan to increase control of NIH grants appears ‘dead’

STAT · 17h ago

Menopausal Hormone Therapy Thrombotic Risk Varies by Dose, Route of Administration

MedPageToday.com - medical news for physicians · 18h ago

STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise

STAT · 18h ago

📰

Gifts from Friends provides thoughtful way to celebrate

Vanderbilt Health News · 18h ago